Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Lupin Mira 25 Tablet ER

Prescription Icon
Prescription Required

Marketer

Lupin Ltd

Salt Composition

Mirabegron (25mg)

Overview Lupin Mira 25 Tablet ER

Mira 25 Extended-Release tablets, manufactured by Lupin, alleviate overactive bladder symptoms such as excessive or frequent urination, urgent urination, and urinary incontinence. This medication relaxes the bladder muscles, improving its urine storage capacity. Always adhere to your physician's prescribed dosage and duration. It may be taken with or without food; swallow the tablet whole, avoiding crushing or chewing. Discontinuing treatment prematurely may worsen symptoms, so consult your doctor before stopping. Complete the prescribed course for optimal results. Potential side effects include constipation, headache, hypertension, nasal congestion, urinary tract infection, tachycardia, and arthralgia. Report any persistent or bothersome side effects to your doctor promptly. Before starting treatment, disclose all other medications and pre-existing health conditions, including pregnancy or breastfeeding. Patients with hepatic or renal impairment require close monitoring and regular check-ups as directed by their doctor.

Uses of Lupin Mira 25 Tablet ER

Managing symptoms associated with overactive bladder

Major Benefits of Lupin Mira 25 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Lupin Mira 25 ER tablets. Always swallow the tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, but consistency in timing is recommended.

Common Side effects of Lupin Mira 25 Tablet ER:

  • Constipation
  • Headache
  • High blood pressure
  • Nasal inflammation
  • Urinary tract infection
  • Fast heart rate
  • Joint pain

How to use Lupin Mira 25 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Lupin Mira 25 Extended-Release tablet whole; avoid crushing, chewing, or breaking it. This medicine can be consumed with or without food, however, consistent timing is recommended.

How Lupin Mira 25 Tablet ER works:

Lupin Mira 25 Extended-Release tablets contain a beta-3 adrenergic agonist. This medication's mechanism involves stimulating bladder receptors, resulting in detrusor muscle relaxation and reduced urinary urgency, frequency, and incontinence.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when using Lupin Mira 25 Tablet ER with alcohol. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Lupin Mira 25 Tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Lupin Mira 25mg tablets may pose a risk to breastfeeding infants. Preliminary studies in humans indicate potential transfer of the medication into breast milk, with possible adverse effects on the child.

DrivingDrivingSAFE

Extended-release Lupin Mira 25mg tablets typically do not impair driving ability.

KidneyKidneyCAUTION

Extended-release Mira 25 tablets (Lupin) require careful administration in individuals with advanced kidney impairment. Dosage modification for Mira 25 ER tablets may be necessary. Physician consultation is recommended.

LiverLiverCAUTION

Patients with liver impairment should use Mira 25 Extended-Release tablets cautiously, potentially requiring dosage modification. Consult a physician. The medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Lupin Mira 25 Tablet ER :

Should you forget a dose of Lupin Mira 25 Extended-Release Tablet, take it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Never take a double dose.

Facts to Know About Lupin Mira 25 Tablet ER

LabelValue
Chemical Category Anilide-based compound
Developing Habits No.
Treatment Category Urological Care
Actions β3-Adrenergic receptor agonist (bladder-selective)

FAQs on Lupin Mira 25 Tablet ER

Optimal benefits from Lupin Mira 25 Tablet ER may become apparent after eight weeks or more of treatment. Dosage adjustments may be considered after four to eight weeks, depending on individual response.
Continue taking Lupin Mira 25 Tablet ER even if your symptoms improve. This medication doesn't cure overactive bladder, but manages urgency, frequency, and incontinence. Stopping treatment could bring back your symptoms.
Lupin Mira 25 Tablet ER shouldn't interfere with your sleep. Consult your doctor about any sleep-related concerns.
Lupin Mira 25 Tablet ER should not be given to children under 18, as its safety and efficacy in this age group haven't been established.
No, consistent daily use, as prescribed, is crucial. This medication manages your condition, not cures it. Intermittent use prevents your bladder from adapting fully, leading to ineffective treatment and symptom recurrence.
Lupin Mira 25 Tablet ER may cause urinary tract infections (kidneys, ureters, bladder, or urethra), though this is not universal. Renal stones and bladder pain are rare reported side effects. Patients with pre-existing kidney problems should use caution and report any kidney-related symptoms to their doctor immediately.
Lupin Mira 25 Tablet ER may raise blood pressure in some individuals; therefore, careful monitoring is crucial if you have hypertension. This medication is contraindicated in patients with severe, uncontrolled high blood pressure.
Seek immediate medical help, regardless of whether you feel symptoms. A Lupin Mira 25 Tablet ER overdose can elevate heart rate and blood pressure, potentially causing severe headache, palpitations, chest pain, and fatigue.
Lupin Mira 25 Tablet ER
317
MRP 386
17% off